My Favorite Biotech Stock Right Now

Veeva Systems (NYSE: VEEV) has proven how valuable software can be in organizing clinical trial data. Schrodinger's (NASDAQ: SDGR) solution is even more vital, in my opinion, as it's helping drug companies navigate drug discovery. Schrodinger helps big pharma find the right molecule for the right target, and it helps them do it a lot quicker than normal human research.

In this clip from Fool Live, Corinne Cardina, the bureau chief of healthcare and cannabis at Fool.com, and Motley Fool writer Taylor Carmichael discuss why Schrodinger is his favorite biotech stock right now. This segment was recorded on June 18.

Continue reading

Source Fool.com